WHO’s 2026 Cancer Report: Why Pancreatic Cancer Early...
July 31, 2026
Estimated New Cases in
2026
Estimated Deaths in
2026
Our mission: to increase the 5 year survival rate for pancreatic cancer from 13% to 50%.
By making a donation to the PRECEDE Foundation, you become a vital part of the movement driving change. Together, we can make a difference and create a future where pancreatic cancer is not only detectable early but also preventable. Your donation allows us to have a meaningful impact on the lives of those affected by pancreatic cancer.
On August 26, 2026, the U.S. Food and Drug Administration
Meet Kimberly Ku, MD, Principal Investigator for PRECEDE at Illinois
A Q&A with Dr. George Zogopoulos about PRECEDE’s global clinical
PRECEDE proceeds go towards research to detect pancreatic cancers earlier, saving thousands of lives from the world’s deadliest cancer.
This revolutionary effort is for early detection, screening and prevention for pancreatic cancer.
To All Our Sponsors & Partners
